Latest Breaking News On - Polpharma biologic - Page 1 : comparemela.com

Poland's biopharmaceutical innovation creates 'win-win' game for economy, patients – EURACTIV.com

Poland's biopharmaceutical innovation creates 'win-win' game for economy, patients – EURACTIV.com
euractiv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euractiv.com Daily Mail and Mail on Sunday newspapers.

Paulina mozolewskaPiotr koryckiKrzysztof kopePolpharma biologicsNational drug manufacturersEuropean medicines agencyEuropean commissionCentral statistical officeCommittee for medicinal products human useMedicinal productsHuman usePolpharma biologicStatistical officeZoran radosavljevic

FDA Approves First Biosimilar of Natalizumab for the Treatment of Relapsing Multiple Sclerosis

The FDA is the first regulatory agency globally to approve natalizumab-sztn as a biosimilar for natalizumab.

United statesPolpharma biologicsMichael soldanEuropean medicines agencyElan pharmaceuticals incPolpharma biologics groupNational institutes of neurological disordersMultiple sclerosis journalPolpharma biologicRisk evaluationMitigation strategyNeurological disordersUpdated january

Declining MS Sales for Historic Powerhouse Biogen Point to Shifting Tides in the Multiple Sclerosis Market According to Spherix Global Insights

/PRNewswire/ According to Biogen s earnings call on Wednesday, February 15, 2023, sales for its multiple sclerosis (MS) franchise are down for the third.

Gemma mcfaddenScott uphamCorporate communicationsSpherix networkRealtime dynamixSpherix global insightsPolpharma biologicLaunch dynamixRealworld dynamixTime dynamixWorld dynamixGlobal insightsGlobal insights contactsSenior insights directorSpherix global insightMedical pharmaceuticals

Declining MS Sales for Historic Powerhouse Biogen Point to Shifting Tides in the Multiple Sclerosis Market According to Spherix Global Insights

Declining MS Sales for Historic Powerhouse Biogen Point to Shifting Tides in the Multiple Sclerosis Market According to Spherix Global Insights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Gemma mcfaddenScott uphamCorporate communicationsSpherix networkRealtime dynamixSpherix global insightsPolpharma biologicLaunch dynamixRealworld dynamixTime dynamixWorld dynamixGlobal insightsGlobal insights contactsSenior insights directorNeurology scott uphamSpherix global insight

MS News That Caught My Eye: Vitamin D, Brain Health, Digoxin, Natalizumab

MS News That Caught My Eye: Vitamin D, Brain Health, Digoxin, Natalizumab
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Drug administrationMultiple vitamind related polymorphismsMultiple sclerosis severityPreliminary findingsMultiple sclerosisPolpharma biologic